Literature DB >> 31097535

Stem cell transplant in MF: it's time to personalize.

Francesco Passamonti1.   

Abstract

Mesh：

Year:  2019        PMID： 31097535     DOI： 10.1182/blood-2019-03-900860

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Improving allogeneic stem cell transplantation in myelofibrosis.

Authors:  Nico Gagelmann; Nicolaus Kröger
Journal:  Int J Hematol       Date:  2022-04-13       Impact factor: 2.490

2.  Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.

Authors:  Barbara Mora; Paola Guglielmelli; Andrew Kuykendall; Elisa Rumi; Margherita Maffioli; Francesca Palandri; Valerio De Stefano; Marianna Caramella; Silvia Salmoiraghi; Jean-Jacques Kiladjian; Jason Gotlib; Alessandra Iurlo; Francisco Cervantes; Marco Ruggeri; Richard T Silver; Francesco Albano; Giulia Benevolo; David M Ross; Matteo G Della Porta; Timothy Devos; Giada Rotunno; Rami S Komrokji; Ilaria C Casetti; Michele Merli; Marco Brociner; Domenica Caramazza; Giuseppe Auteri; Tiziano Barbui; Daniele Cattaneo; Lorenza Bertù; Luca Arcaini; Alessandro M Vannucchi; Francesco Passamonti
Journal:  Leukemia       Date:  2022-08-30       Impact factor: 12.883

Review 3.  Standard care and investigational drugs in the treatment of myelofibrosis.

Authors:  Daniela Barraco; Margherita Maffioli; Francesco Passamonti
Journal:  Drugs Context       Date:  2019-09-26

Review 4.  Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.

Authors:  Barbara Mora; Francesco Passamonti
Journal:  Curr Hematol Malig Rep       Date:  2022-09-01       Impact factor: 4.213

5.  High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis.

Authors:  Nico Gagelmann; Rachel B Salit; Thomas Schroeder; Anita Badbaran; Christina Rautenberg; Victoria Panagiota; Christine Wolschke; Felicitas Thol; Bruno Cassinat; Marie Robin; Michael Heuser; Hans Christian Reinhardt; Bart L Scott; Nicolaus Kröger
Journal:  Hemasphere       Date:  2022-09-30

6.  Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

Authors:  Tariq I Mughal; Michael W Deininger; Nicole Kucine; Giuseppe Saglio; Richard A Van Etten
Journal:  Hemasphere       Date:  2019-08-01

Review 7.  Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.

Authors:  Tariq I Mughal; Naveen Pemmaraju; Bethan Psaila; Jerald Radich; Prithviraj Bose; Thomas Lion; Jean-Jacques Kiladjian; Raajit Rampal; Tania Jain; Srdnan Verstovsek; Abdulraheem Yacoub; Jorge E Cortes; Ruben Mesa; Giuseppe Saglio; Richard A van Etten
Journal:  Hematol Oncol       Date:  2020-09-04       Impact factor: 5.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.